NCT01859624View on ClinicalTrials.gov

Albuterol in Individuals With Late Onset Pompe Disease (LOPD)

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions

Pompe Disease

Interventions

DRUG

Albuterol

Albuterol 4 mg

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER

NCT01859624 - Albuterol in Individuals With Late Onset Pompe Disease (LOPD) | Biotech Hunter | Biotech Hunter